{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR-34a is a pivotal tumor‐suppressive microRNA whose expression is directly induced by p53 following cellular stress, DNA damage, or oncogene activation. Its transcriptional upregulation initiates a feed‐forward loop that reinforces p53 activity and leads to cell cycle arrest, apoptosis, and senescence through the repression of key regulators—including SIRT1, cyclin D1, CDK6, E2F family members, and pro‐apoptotic targets such as p21 and PUMA. In multiple cancer types, silencing of miR-34a through genomic deletions (often at 1p36) or promoter hypermethylation interrupts these tumor‐suppressive pathways, thereby contributing to unchecked proliferation and resistance to chemotherapeutic agents."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its classical functions in cell cycle control, miR-34a critically modulates pathways governing epithelial-to-mesenchymal transition (EMT), metastasis, and cancer stem cell fate. By directly targeting pivotal inducers of EMT and stemness—such as SNAIL, SLUG, c-Met, Notch1, and key components of the Wnt/β-catenin cascade—it impairs tumor cell migration, invasion, and self-renewal. Reduced miR-34a levels in tumors are associated not only with enhanced metastatic potential in cancers like neuroblastoma, glioma, and non–small cell lung carcinoma but also with immune evasion via modulation of PD-L1 and inflammatory cytokine signaling. Moreover, miR-34a has been implicated in governing cell-fate decisions in cancer stem cells and in promoting differentiation in diverse cell types."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe clinical relevance of miR-34a is underscored by its emerging role as a prognostic biomarker and a therapeutic target. In several cancers—including neuroblastoma, prostate cancer, pancreatic cancer, chronic lymphocytic leukemia, and non–small cell lung cancer—diminished miR-34a expression correlates with aggressive disease, poor treatment response, and drug resistance. Preclinical models demonstrate that restoration of miR-34a, either through direct replacement or via combination with other tumor suppressive microRNAs (such as let-7), can inhibit tumor growth, overcome chemoresistance, modify the tumor immune microenvironment, and even regulate metabolic derangements seen in conditions like non-alcoholic fatty liver disease. Additionally, its altered expression in noncancerous settings such as endothelial senescence, dendritic cell differentiation, and possibly cardiac remodeling points to broad implications in tissue homeostasis and disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "33", "end_ref": "42"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Munekazu Yamakuchi, Marcella Ferlito, Charles J Lowenstein "}, {"type": "b", "children": [{"type": "t", "text": "miR-34a repression of SIRT1 regulates apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0801613105"}], "href": "https://doi.org/10.1073/pnas.0801613105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18755897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18755897"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "H Hermeking "}, {"type": "b", "children": [{"type": "t", "text": "The miR-34 family in cancer and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2009.56"}], "href": "https://doi.org/10.1038/cdd.2009.56"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19461653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19461653"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Valery Tarasov, Peter Jung, Berlinda Verdoodt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.6.13.4436"}], "href": "https://doi.org/10.4161/cc.6.13.4436"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17554199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17554199"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hiroshi Tazawa, Naoto Tsuchiya, Masashi Izumiya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0707351104"}], "href": "https://doi.org/10.1073/pnas.0707351104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17875987"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17875987"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Dmitri Lodygin, Valery Tarasov, Alexey Epanchintsev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.7.16.6533"}], "href": "https://doi.org/10.4161/cc.7.16.6533"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18719384"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18719384"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Fang Sun, Hanjiang Fu, Qin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2008.03.057"}], "href": "https://doi.org/10.1016/j.febslet.2008.03.057"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18406353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18406353"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Qing Ji, Xinbao Hao, Yang Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-8-266"}], "href": "https://doi.org/10.1186/1471-2407-8-266"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18803879"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18803879"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yasunori Fujita, Keitaro Kojima, Nanako Hamada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2008.09.086"}], "href": "https://doi.org/10.1016/j.bbrc.2008.09.086"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18834855"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18834855"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Takashi Ito, Shusuke Yagi, Munekazu Yamakuchi "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-34a regulation of endothelial senescence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.07.012"}], "href": "https://doi.org/10.1016/j.bbrc.2010.07.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20627091"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20627091"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "N R Christoffersen, R Shalgi, L B Frankel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2009.109"}], "href": "https://doi.org/10.1038/cdd.2009.109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19696787"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19696787"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yukihiro Akao, Shunsuke Noguchi, Akio Iio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2010.10.006"}], "href": "https://doi.org/10.1016/j.canlet.2010.10.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21067862"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21067862"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "C Welch, Y Chen, R L Stallings "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1210293"}], "href": "https://doi.org/10.1038/sj.onc.1210293"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17297439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17297439"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Matjaz Rokavec, Meryem Gülfem Öner, Huihui Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI73531"}], "href": "https://doi.org/10.1172/JCI73531"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24642471"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24642471"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Qing Ji, Xinbao Hao, Min Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0006816"}], "href": "https://doi.org/10.1371/journal.pone.0006816"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19714243"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19714243"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Helge Siemens, Rene Jackstadt, Sabine Hünten, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.10.24.18552"}], "href": "https://doi.org/10.4161/cc.10.24.18552"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22134354"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22134354"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Pengyuan Yang, Qi-Jing Li, Yuxiong Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2012.07.023"}], "href": "https://doi.org/10.1016/j.ccr.2012.07.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22975373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22975373"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Na Li, Hanjiang Fu, Yi Tie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2008.09.035"}], "href": "https://doi.org/10.1016/j.canlet.2008.09.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19006648"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19006648"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Nam Hee Kim, Hyun Sil Kim, Xiao-Yan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.201103097"}], "href": "https://doi.org/10.1083/jcb.201103097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22024162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22024162"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Elena Gallardo, Alfons Navarro, Nuria Viñolas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgp219"}], "href": "https://doi.org/10.1093/carcin/bgp219"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19736307"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19736307"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Pengcheng Bu, Kai-Yuan Chen, Joyce Huan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Stem Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.stem.2013.03.002"}], "href": "https://doi.org/10.1016/j.stem.2013.03.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23642368"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23642368"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Fadila Guessous, Ying Zhang, Alex Kofman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-34a is tumor suppressive in brain tumors and glioma stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.9.6.10987"}], "href": "https://doi.org/10.4161/cc.9.6.10987"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20190569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20190569"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Kristina A Cole, Edward F Attiyeh, Yael P Mosse, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-07-2102"}], "href": "https://doi.org/10.1158/1541-7786.MCR-07-2102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18505919"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18505919"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Xi Wang, Jinge Li, Ke Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2014.12.003"}], "href": "https://doi.org/10.1016/j.cellsig.2014.12.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25499621"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25499621"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Sara T Hashimi, Jennifer A Fulcher, Margaret H Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2008-09-179150"}], "href": "https://doi.org/10.1182/blood-2008-09-179150"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19398721"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19398721"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "J S Wei, Y K Song, S Durinck, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The MYCN oncogene is a direct target of miR-34a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2008.154"}], "href": "https://doi.org/10.1038/onc.2008.154"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18504438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18504438"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Ronald T K Pang, Carmen O N Leung, Tian-Min Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgq066"}], "href": "https://doi.org/10.1093/carcin/bgq066"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20351093"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20351093"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "G Mudduluru, P Ceppi, R Kumarswamy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.13"}], "href": "https://doi.org/10.1038/onc.2011.13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21317930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21317930"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Ashish Lal, Marshall P Thomas, Gabriel Altschuler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1002363"}], "href": "https://doi.org/10.1371/journal.pgen.1002363"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22102825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22102825"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Kang Yan, Jie Gao, Tongtao Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0033778"}], "href": "https://doi.org/10.1371/journal.pone.0033778"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22457788"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22457788"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "A L Kasinski, K Kelnar, C Stahlhut, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.282"}], "href": "https://doi.org/10.1038/onc.2014.282"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25174400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25174400"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Claire Corcoran, Sweta Rani, Lorraine O'Driscoll "}, {"type": "b", "children": [{"type": "t", "text": "miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pros.22848"}], "href": "https://doi.org/10.1002/pros.22848"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25053345"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25053345"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Nam Hee Kim, Hyun Sil Kim, Nam-Gyun Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53 and microRNA-34 are suppressors of canonical Wnt signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.2001744"}], "href": "https://doi.org/10.1126/scisignal.2001744"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22045851"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22045851"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Sen Matsumoto, Yasuhiko Sakata, Shinichiro Suna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.113.301209"}], "href": "https://doi.org/10.1161/CIRCRESAHA.113.301209"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23743335"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23743335"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Rui E Castro, Duarte M S Ferreira, Marta B Afonso, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jhep.2012.08.008"}], "href": "https://doi.org/10.1016/j.jhep.2012.08.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22902550"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22902550"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Rongfang He, Peng Liu, Xiaoming Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-017-0614-1"}], "href": "https://doi.org/10.1186/s13046-017-0614-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29037220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29037220"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Markus Vogt, Johanna Munding, Martha Grüner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virchows Arch (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00428-010-1030-5"}], "href": "https://doi.org/10.1007/s00428-010-1030-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21225432"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21225432"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "X J Li, Z J Ren, J H Tang "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-34a: a potential therapeutic target in human cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2014.270"}], "href": "https://doi.org/10.1038/cddis.2014.270"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25032850"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25032850"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Yao-Yin Li, Yi-Wei Tao, Shuo Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2018.09.006"}], "href": "https://doi.org/10.1016/j.ebiom.2018.09.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30243489"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30243489"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Hua Liu, Haoyu Deng, Yajie Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-018-0950-9"}], "href": "https://doi.org/10.1186/s13046-018-0950-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30463570"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30463570"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Thorsten Zenz, Julia Mohr, Eric Eldering, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-34a as part of the resistance network in chronic lymphocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2008-08-172254"}], "href": "https://doi.org/10.1182/blood-2008-08-172254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18941118"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18941118"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Thorsten Zenz, Sonja Häbe, Tina Denzel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2009-05-224071"}], "href": "https://doi.org/10.1182/blood-2009-05-224071"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19643983"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19643983"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Dara Nalls, Su-Ni Tang, Marianna Rodova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0024099"}], "href": "https://doi.org/10.1371/journal.pone.0024099"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21909380"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21909380"}]}]}]}